Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study
Kamran A. Ahmed(Moffitt Cancer Center), Hyo S. Han(Moffitt Cancer Center), Aixa Soyano(Moffitt Cancer Center), Min Wang(Sun Yat-sen University), Loretta Loftus(Moffitt Cancer Center), Nam Tran(Moffitt Cancer Center), Avan Armaghani(Moffitt Cancer Center), Ya-Yu Tsai(Moffitt Cancer Center), Brian J. Czerniecki(Moffitt Cancer Center), Marilin Rosa(Moffitt Cancer Center), Jimmy J. Caudell(Moffitt Cancer Center), Younchul Kim(Moffitt Cancer Center), Arnold B. Etame(Moffitt Cancer Center), Peter Forsyth(Moffitt Cancer Center), Hatem Soliman(Moffitt Cancer Center), Roberto Díaz(Moffitt Cancer Center), Sungjune Kim(Agency for Defense Development), Ricardo Costa(Moffitt Cancer Center), John A. Arrington(Moffitt Cancer Center), Michelle DeJesus(Moffitt Cancer Center)
Cited by 7
Related Papers
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical Trial
|Journal of Clinical Oncology|2004|888
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
|Journal of the National Comprehensive Cancer Network|2022|532